The international pharmaceutical industry gathered in Milan, Italy, from October 6 to 8, 2026, for CPHI, one of the world’s major events dedicated to pharmaceutical manufacturing, ingredients, technologies, and industry services.
The exhibition brought together pharmaceutical manufacturers, raw material suppliers, technology providers, and industry professionals from different countries, creating opportunities to exchange knowledge, explore new markets, and strengthen international business relationships.
One of the main highlights of this year’s event was the growing importance of cooperation across the pharmaceutical supply chain. Companies explored opportunities to diversify their sources of active pharmaceutical ingredients (APIs), improve procurement strategies, and establish more reliable international partnerships.
The exhibition also provided a platform for discussions about pharmaceutical quality standards, contract manufacturing, research and development, and the challenges facing international pharmaceutical trade.
With increasing attention to supply chain resilience, pharmaceutical companies are looking beyond traditional sourcing approaches and exploring alternative markets and manufacturing partnerships.
Direct communication between manufacturers and suppliers remains particularly valuable, allowing companies to gain a better understanding of production capabilities, technical requirements, and potential areas of cooperation.
Events such as CPHI demonstrate how international exhibitions can support the exchange of expertise and strengthen connections between different sectors of the pharmaceutical industry.
As the global pharmaceutical market continues to evolve, international collaboration, reliable supply networks, and access to specialized manufacturing knowledge are expected to remain important factors in sustainable industry development.
